KLF4 and idiopathic pulmonary fibrosis: Our work thus identifies KLF4 as a pivotal brake on fibroblast activation and lung fibrogenesis whose potentiation is pharmacologically tractable, suggesting a novel therapeutic approach in fibrotic diseases such as IPF.